FMC regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: FCM regimen
Overview
Overview
FMC regimen refers to a regimen consisting of fludarabine, cyclophosphamide and mitoxantrone used in the treatment of resistant or relapsed chronic lymphocytic leukaemia. [1]
Regimen
Regimen
FFludarabine
CCyclophosphamide
MMitoxantrone
References
References
- ↑ 1.0 1.1 Bosch F, Ferrer A, López-Guillermo A, Giné E, Bellosillo B, Villamor N; et al. (2002). “Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia”. Br J Haematol. 119 (4): 976–84. PMID 12472576.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH